These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease. Djaldetti R; Ziv I; Melamed E Isr J Med Sci; 1996 Dec; 32(12):1224-7. PubMed ID: 9007159 [TBL] [Abstract][Full Text] [Related]
10. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary. Quinn NP J Neurol; 2003 Jan; 250(1):97. PubMed ID: 12528000 [No Abstract] [Full Text] [Related]
11. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
12. Treatments for Parkinson's disease. Health News; 2000 Jun; 6(6):8. PubMed ID: 10865523 [No Abstract] [Full Text] [Related]
13. Deprenyl in Parkinson's disease. Korczyn AD; Nisipeanu P Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617 [No Abstract] [Full Text] [Related]
14. Levodopa in the treatment of Parkinson's disease: current controversies. Gerlach M; Reichmann H; Riederer P Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130 [No Abstract] [Full Text] [Related]
15. Parkinson's disease. Clarke C; Moore AP Clin Evid; 2003 Dec; (10):1582-98. PubMed ID: 15555162 [No Abstract] [Full Text] [Related]
17. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages. MacMahon DG; Bland R BMJ; 1996 Mar; 312(7032):703; author reply 704-5. PubMed ID: 8597748 [No Abstract] [Full Text] [Related]
18. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used. Gerlach M; Riederer P; Vogt H BMJ; 1996 Mar; 312(7032):704; author reply 704-5. PubMed ID: 8597750 [No Abstract] [Full Text] [Related]
19. [ What drug strategies are advisable for patients with advanced-stage Parkinson's]. Brefel-Courbon C Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():120-59. PubMed ID: 10916046 [No Abstract] [Full Text] [Related]